Jorge Maspero from Fundación CIDEA, Argentina, presents his article published in Allergy on a post-hoc analysis from the LIBERTY ASTHMA QUEST on the efficacy of dupilumab for the treatment of uncontrolled, moderate-to-severe asthma in adolescents. A 52-week dupilumab treatment improved lung function and reduced severe exacerbations, FeNO and IgE levels.
Maspero, J.F., FitzGerald, J.M., Pavord, I.D., et al. (2021), Dupilumab efficacy in adolescents with uncontrolled, moderate-to-severe asthma: LIBERTY ASTHMA QUEST. Allergy. [ Ссылка ]
Follow Allergy on:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
LinkedIn: [ Ссылка ]
Instagram: [ Ссылка ]
Like, share and comment on our videos, thank you.
[ Ссылка ]
